Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 380 of 5804
-
Brain surgery gets a GPS: new trial aims to save speech and movement
Disease control Recruiting nowThis study is designed for patients with brain tumors located in eloquent brain areas involved in language, motor, or major functional brain networks. The purpose of the study is to determine whether connectome-guided navigation-assisted microsurgical resection can better preserv…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Supercharged immune cells take on tough lupus cases
Disease control Recruiting nowThis is an investigator-initiated trial aimed at assessing the safety and efficacy of ultra-fast autologous CD19-targeted CAR-T cells in the treatment of refractory systemic lupus erythematosus.
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Eye scan could spot Parkinson's years before symptoms worsen
Diagnosis Recruiting nowThe objective of this observational study is to investigate whether non-invasive fundus retinal detection technology can be used for the early diagnosis of parkinson's disease (PD). It aims to answer the following primary questions: the sensitivity and specificity of non-invasive…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New stroke device aims to quickly clear blocked arteries
Disease control Recruiting nowThe primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)
Sponsor: Penumbra Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New radiation approach aims to improve sarcoma surgery outcomes
Disease control Not yet recruiting"This prospective, single-institution Phase I/II clinical trial investigates the safety, feasibility, and preliminary efficacy of preoperative carbon-ion radiotherapy (CIRT) for patients with resectable soft tissue sarcoma. Given the radioresistant nature of sarcomas and the limi…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New Dual-Action drug shows promise for kidney cancer patients
Disease control ENROLLING_BY_INVITATIONThis study is testing a new medicine called AK112 (Yivoximab) for people with advanced kidney cancer that has spread to other parts of the body (metastatic clear cell renal cell carcinoma). AK112 is a special kind of drug called a dual-target antibody that works in two ways: it h…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New imaging-guided radiation aims to halt kidney cancer spread
Disease control Recruiting nowThis is a prospective, single-arm study in adults with recurrent or metastatic clear cell renal cell carcinoma (ccRCC). Participants will receive standard systemic therapy (targeted therapy plus anti-PD-1 immunotherapy) and undergo dual PET/CT imaging (FDG PET/CT and a CAIX-targe…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Could a shorter TB course work for those with unclear test results?
Disease control Not yet recruitingPeople living in high TB burden communities who undergo active case finding for TB may have chest X-ray changes suggestive of TB but their sputum test can be negative for the TB bacteria or they are unable to provide a sputum sample. This means they have bacteriologically unconfi…
Phase: PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC
-
New fertility drug aims to boost IVF live birth rates
Disease control Recruiting nowThe goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reprod…
Phase: PHASE3 • Sponsor: Granata Bio Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Smart combo attack: new trial matches lung cancer drugs to tumor fingerprints
Disease control Not yet recruitingThis is an open-label umbrella study conducted in first treatment ES-SCLC patients, employing a novel umbrella trial design (biomarker-integrated multi-arm trial with a shared ICI+chemotherapy control arm). Eligible patients were assigned to trial arms based on biomarker expressi…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Weekly injection could tame bleeding in kids with Hard-to-Treat ITP
Disease control Not yet recruitingThe aim is to evaluate safety and efficacy of Romiplostim in the treatment of chronic ITP in children
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug aims to stop skin lymphoma from returning after transplant
Disease control Not yet recruitingAllogeneic hematopoietic stem cell transplantation (alloHSCT) showed efficacy in advanced-stage, high-risk, treatment sensitive cutaneous T-cell lymphomas (CTCL) in a prospective, propensity score-matched controlled study (CUTALLO) published by our group in the Lancet in 2023. Ne…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC
-
New pill could replace infusions for rare blood disorder
Disease control Not yet recruitingNTQ5082 capsules are a small molecule CFB inhibitor. This study is a multicenter, randomized, open-label, active-controlled Phase III clinical trial designed to evaluate the efficacy and safety of NTQ5082 capsules in the treatment of patients with paroxysmal nocturnal hemoglobinu…
Phase: PHASE3 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 17:59 UTC
-
New cholera vaccine trial aims to protect south africans of all ages
⭐️ VACCINE ⭐️ Recruiting nowThis Phase I/III clinical trial is intended to establish the immunogenicity and safety profile of Biovac OCV-S compared to available WHO pre-qualified vaccine Euvichol®-Plus in healthy adults and children and in adult people living with HIV (PLWH). The lot-to-lot consistency of B…
Phase: PHASE3 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:10 UTC
-
One procedure to replace lifelong blood thinners? new trial tests dual heart fix for stroke survivors
Disease control Recruiting nowThe project is a multicenter, open-label, randomized medical experiment, which was designed to evaluate the efficacy and safety of single-stage pulmonary vein isolation (PVI) and implantation of left atrial appendage occluder (LAAO) in comparison with either isolated LAAO implant…
Phase: PHASE4 • Sponsor: Medical University of Silesia • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can brain scans and gut bacteria predict suicide risk in young people?
Knowledge-focused Not yet recruitingThe YOU-SURF project is at the forefront of youth suicide prevention, with the goal of integrating multimodal clinical and neurobiological data to comprehensively identify risk factors and the most effective intervention strategies. Suicide is one of the leading causes of death a…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Immune system clues guide lighter chemo in breast cancer trial
Disease control Recruiting nowThis is a phase II clinical study testing a more personalized and lighter chemotherapy approach for women with stage I or II triple-negative breast cancer. The treatment is adjusted based on signs from the immune system (called tumor-infiltrating lymphocytes, or TILs) and imaging…
Phase: PHASE2 • Sponsor: D'Or Institute for Research and Education • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill could replace needles for anemia in dialysis patients
Disease control Recruiting nowThis is a phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in anemic patients with End-Stage-Kidney-Disease (ESKD)
Phase: PHASE3 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug aims to save lives in severe respiratory failure
Disease control Recruiting nowTo evaluate the efficacy, safety and tolerability of STSA-1002 injection in patients with acute respiratory distress syndrome
Phase: PHASE3 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Promising drug targets HER2 cancers in new trial
Disease control Recruiting nowAlterations in the HER2 gene are involved in the development of cancer. These abnormalities are found at highly variable rates (from approximately 2% to 60%) in cancers of the lung, breast, stomach, bile ducts, salivary glands, colon, endometrium, uterus, bladder, bones, blood, e…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC